Page 64 - Clinical Small Animal Internal Medicine
P. 64

32  Section 2  Endocrine Disease

               200                                            endocrine tissue. Examples include primary hypothyroid­
  VetBooks.ir  175                                            ism in dogs and hypoadrenocorticism (Addison disease)
                                                              in dogs and cats. The immune‐mediated destruction and
               150
                                                              gradual loss of hormone secretion activate negative feed­
             Cortisol (nmol/L)  125  Hyperadrenocorticism     back mechanisms so that a period of compensation typi­
                                                              cally occurs. For example, levels of TSH would be expected
               100
                                                              to rise in dogs with primary hypothyroidism, possibly
                75
                                                              immune‐mediated destruction results in loss of sufficient
                50                              Normal        even before clinical signs are noted. Eventually, the
                                                              endocrine tissue so that the hormone secretion declines
                25
                                                              to the point that clinical signs of deficiency are seen.
                 0                                              Often, endocrine hyperfunction conditions result
                      0               4               8       from overactivity of endocrine cells associated with
                                   Hours                      either hyperplasia or neoplasia. Often, these affected
                                                              cells not only possess increased cell division rates but
            Figure 4.2  Low‐dose dexamethasone (Dex) suppression patterns
            in dogs. Administration of Dex activates negative feedback in the   also lose (or show lessened) negative feedback control.
            hypothalamus and pituitary, resulting in a decline in ACTH   Examples include the most common form of hyper­
            secretion. In turn, the drop in ACTH rapidly results in a decline in   adrenocorticism in dogs (pituitary‐dependent hyper­
            levels of cortisol from the adrenal. In dogs with normal pituitary‐  adrenocorticism),  primary  hyperparathyroidism,  and
            adrenal function, cortisol levels are suppressed (stay below the
            dotted line) at four and eight hours after Dex. The pituitary tumor   insulinoma. Feline hyperthyroidism is associated with a
            present in dogs with pituitary‐dependent hyperadrenocorticism   similar process occurring in follicles; these cells show
            possesses resistance to feedback, so cortisol levels are not   increased activity (resulting in excessive secretion of T4)
            suppressed below the normal cut‐off value at both time points.  in the absence of trophic drive from TSH.
                                                                Endocrine diseases can result from many other poten­
            pituitary tumors in canine hyperadrenocorticism (corti­  tial mechanisms. Mutations in receptors can render them
            cotroph tumors) have an inherent degree of resistance to   incapable of responding to the hormone ligand or can
            feedback and therefore affected dogs do not demonstrate   result in continual activation in the absence of hormone.
            the same feedback responsiveness to a low dose of dexa­  In other situations, diseases occur as a consequence of
            methasone as do unaffected dogs (Figure 4.2).     receptor insensitivity to the hormone in the absence of
             Insulinomas also have abnormalities in negative feed­  mutations. For example, in type 2 or noninsulin‐depend­
            back. Whereas the normal beta cell responds to a drop in   ent diabetes, the insulin receptor has reduced responsive­
            circulating glucose levels by shutting off insulin secretion,   ness to insulin, often related to obesity.
            in patients with insulinomas, the tumor cells do not
            respond appropriately to this decline in glucose and insu­
            lin secretion is maintained in the face of hypoglycemia.     Hormone Measurement
            Documentation of an elevated insulin level in blood col­
            lected from a fasted animal experiencing hypoglycemia is   For many years, radioimmunoassay (RIA) was the stand­
            diagnostic for this tumor. Levels of parathyroid hormone   ard method used to measure hormone concentration in
            (PTH) should be evaluated in conjunction with calcium   blood. RIA employed a radioactive‐tagged version of the
            (total or free) levels. If normal parathyroid gland function   hormone and an antibody made against it. Nontagged
            is present, the presence of hypercalcemia will be accom­  hormone, either in the form of standard, purified hor­
            panied by low levels of PTH. However, hypercalcemia   mone or present in patient sample, was mixed with the
            occurring in conjunction with an elevated PTH concen­  tagged hormone and competed for a limited number of
            tration is consistent with a defect in parathyroid gland   antibody‐binding sites. In this way, displacement curves
            feedback, most likely related to a parathyroid adenoma   were generated, so that tubes containing increasing
            (primary hyperparathyroidism).                    amounts of nontagged hormone displaced tagged hor­
                                                              mone from antibody. Standard curves were generated by
                                                              adding known amounts of nontagged hormone to tubes,
              Endocrine Disease                               and radioactivity in tubes with patient sample was then
                                                              compared to that from the standards. Use of radioactiv­
            Endocrine diseases usually manifest as hypo‐ or hyper­  ity as the mode of detection allowed for a high level of
            function of an endocrine tissue. In many cases, the cause   sensitivity in RIA, a must when attempting to measure
                                                                                                           −9
            of hypofunction involves the immune system (autoim­  substances circulating in pico‐ (10 −12 ) or nano‐ (10 )
            mune attack) resulting in a gradual destruction of the   gram amounts.
   59   60   61   62   63   64   65   66   67   68   69